Palisade Capital Management LLC Seagen Inc. Transaction History

Palisade Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$127.59 - $203.08 $6,507 - $10,357	-51 Reduced 2.86%	1,734 $351,000
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $25,234 - $29,921	-215 Reduced 10.75%	1,785 $229,000
Q4 2020 Feb 11, 2021	BUY	$164.63 - $211.93 $329,260 - $423,860	2,000 New	2,000 $350,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.